1. Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge–Attitudes–Practices Survey.
- Author
-
Laymouna, Moustafa, Ma, Yuanchao, Lessard, David, Engler, Kim, Therrien, Rachel, Schuster, Tibor, Vicente, Serge, Achiche, Sofiane, El Haj, Maria Nait, Lemire, Benoît, Kawaiah, Abdalwahab, and Lebouché, Bertrand
- Subjects
HEALTH literacy ,HEALTH services accessibility ,CROSS-sectional method ,SCALE analysis (Psychology) ,HIV ,SELF-efficacy ,CRONBACH'S alpha ,RESEARCH funding ,ARTIFICIAL intelligence ,STATISTICAL sampling ,MEDICAL care ,RESEARCH evaluation ,PATIENT care ,DECISION making in clinical medicine ,DESCRIPTIVE statistics ,EXPERIMENTAL design ,SURVEYS ,RESEARCH methodology ,ATTITUDES of medical personnel ,PSYCHOMETRICS ,NEEDS assessment ,QUALITY assurance ,SOCIODEMOGRAPHIC factors ,DATA analysis software ,CONFIDENCE intervals ,USER interfaces - Abstract
Background: Pharmacists need up-to-date knowledge and decision-making support in HIV care. We aim to develop MARVIN-Pharma, an adapted artificial intelligence-based chatbot initially for people with HIV, to assist pharmacists in considering evidence-based needs. Methods: From December 2022 to December 2023, an online needs-assessment survey evaluated Québec pharmacists' knowledge, attitudes, involvement, and barriers relative to HIV care, alongside perceptions relevant to the usability of MARVIN-Pharma. Recruitment involved convenience and snowball sampling, targeting National HIV and Hepatitis Mentoring Program affiliates. Results: Forty-one pharmacists (28 community, 13 hospital-based) across 15 Québec municipalities participated. Participants perceived their HIV knowledge as moderate (M = 3.74/6). They held largely favorable attitudes towards providing HIV care (M = 4.02/6). They reported a "little" involvement in the delivery of HIV care services (M = 2.08/5), most often ART adherence counseling, refilling, and monitoring. The most common barriers reported to HIV care delivery were a lack of time, staff resources, clinical tools, and HIV information/training, with pharmacists at least somewhat agreeing that they experienced each (M ≥ 4.00/6). On average, MARVIN-Pharma's acceptability and compatibility were in the 'undecided' range (M = 4.34, M = 4.13/7, respectively), while pharmacists agreed to their self-efficacy to use online health services (M = 5.6/7). Conclusion: MARVIN-Pharma might help address pharmacists' knowledge gaps and barriers to HIV treatment and care, but pharmacist engagement in the chatbot's development seems vital for its future uptake and usability. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF